Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

The Boston Scientific Watchman device have performed better than expected in real-world patients outside of trials since it was introduced in 2015, according to data from the NCDR LAAO Registry. #ACC21 #ACC2021 #LAA #Watchman
Feature | Left Atrial Appendage (LAA) Occluders

May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was ...

Home May 16, 2021
Home
News | Left Atrial Appendage (LAA) Occluders

May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib) ...

Home May 15, 2021
Home
News | EP Lab

May 12, 2021 — Galaxy Medical and Japan Lifeline announced an exclusive distribution agreement for the Alpha1 ablation ...

Home May 12, 2021
Home
News | Atrial Fibrillation

April 19, 2021 — National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $462,689 to Rhythm ...

Home April 19, 2021
Home
News | EP Lab

March 23, 2021 — Researchers at Columbia University are using cardiac ultrasound to improve the critical need to ...

Home March 23, 2021
Home
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Feature | ACC | Dave Fornell, Editor

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home May 18, 2021
Home
News | Atrial Fibrillation

March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug ...

Home March 03, 2021
Home
The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.
Feature | By Dave Fornell, Editor

March 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home March 01, 2021
Home
News | Atrial Fibrillation

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system ...

Home January 29, 2021
Home
Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 
Feature | Atrial Fibrillation | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. 


But while this ...

Home January 27, 2021
Home
News | Atrial Fibrillation

December 23, 2020 — The American College of Cardiology (ACC) and the American Heart Association (AHA) has made two ...

Home December 23, 2020
Home
Videos | EP Lab

Oussama Wazni, M.D., section head, electrophysiology, Cleveland Clinic, discusses the results of the recent STOP AF ...

Home December 04, 2020
Home
News | EP Lab

December 3, 2020 – Attune Medical reports the first major peer-reviewed clinical publication using its ensoETM device in ...

Home December 03, 2020
Home
News | Artificial Intelligence

November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive a ...

Home November 24, 2020
Home
Videos | Atrial Fibrillation

Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking VITAL ...

Home November 18, 2020
Home
Subscribe Now